AnaptysBio, Inc. (ANAB)
NASDAQ·Healthcare·Biotechnology
$49.62
—
Mkt Cap $1.46B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (35 analysts)
$79.17
Range $70.00 – $95.00
Implied Upside
+59.6%
Consensus $79.17 vs current $49.62
NASDAQ·Healthcare·Biotechnology
$49.62
—
Mkt Cap $1.46B
Buy
8
Hold
0
Sell
0
Price Target (35 analysts)
$79.17
Range $70.00 – $95.00
+59.6%
Consensus $79.17 vs current $49.62